Darwinian interventions: taming pathogens through evolutionary ecology

Trends in Parasitology

Volumn 26, Issue 2, 2010, Pages 83-92

  Williams, Paul David ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; HEAT SHOCK PROTEIN 90; VACCINE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; BACTERIAL MUTATION; BACTERIAL VIRULENCE; BIRD DISEASE; BORDETELLA PERTUSSIS; CANDIDA ALBICANS; CLOSTRIDIUM DIFFICILE; CORYNEBACTERIUM DIPHTHERIAE; ESCHERICHIA COLI; EVOLUTIONARY ADAPTATION; HAEMOPHILUS INFLUENZAE; HEPATITIS B; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INFECTIOUS BURSAL DISEASE VIRUS; INFLUENZA VIRUS A; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MYCOBACTERIUM; MYXOMA VIRUS; NEISSERIA MENINGITIDIS; NONHUMAN; PLASMODIUM CHABAUDI; PLASMODIUM FALCIPARUM; PSEUDOMONAS AERUGINOSA; REVIEW; SOURCE SINK RELATIONSHIP; STREPTOCOCCUS PNEUMONIAE; VANCOMYCIN RESISTANT ENTEROCOCCUS; VIRUS IMMUNITY; VIRUS MUTATION; VIRUS VIRULENCE;

ANIMALS; DRUG RESISTANCE; EVOLUTION, MOLECULAR; HOST-PATHOGEN INTERACTIONS; HUMANS; MODELS, BIOLOGICAL; POPULATION DYNAMICS; SELECTION, GENETIC; SPECIES SPECIFICITY; VIRULENCE;

EID: 74549134628     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2009.11.009     Document Type: Review

References (70)

1. Fisher J.A. The plague makers: how we are creating catastrophic new epidemics- and what we must do to avert them (1994), Simon & Schuster
2. Woolhouse M.E.J., et al. Biological and biomedical implications of the co-evolution of pathogens and their hosts. Nat. Genet. 32 (2002) 569-577
3. Weiss R.A., and McMichael A.J. Social and environmental risk factors in the emergence of infectious diseases. Nat. Med. 10 (2004) S70-S76
4. Jones K.E., et al. Global trends in emerging infectious diseases. Nature 451 (2008) 990-994
5. Palumbi S.R. Evolution - humans as the world's greatest evolutionary force. Science 293 (2001) 1786-1790
6. de Sande-Bruinsma N.V., et al. Antimicrobial drug use and resistance in Europe. Emerg. Infect. Dis. 14 (2008) 1722-1730
7. In: Stearns S.C., and Koella J.C. (Eds). Evolution in health and disease (2008), Oxford University Press
8. Restif O. Evolutionary epidemiology 20 years on: challenges and prospects. Infect. Genet. Evol. 9 (2009) 108-123
9. Lebarbenchon C., et al. Evolution of pathogens in a man-made world. Mol. Ecol. 17 (2008) 475-484
10. Wright G.D. The antibiotic resistome: the nexus of chemical and genetic diversity. Nat. Rev. Microbiol. 5 (2007) 175-186
11. Boni M.F. Vaccination and antigenic drift in influenza. Vaccine 26 (2008) C8-C14
12. Read A.F., and Mackinnon M.J. Pathogen evolution in a vaccinated world. In: Stearns S.C., and Koella J.C. (Eds). Evolution in health and disease (2008), Oxford University Press 139-152
13. Bergstrom C.T., and Feldgarden M. The ecology and evolution of antibiotic-resistant bacteria. In: Stearns S.C., and Koella J.C. (Eds). Evolution in health and disease (2008), Oxford University Press 125-137
14. Mackinnon M.J., et al. Virulence evolution in response to vaccination: the case of malaria. Vaccine 26 (2008) C42-C52
15. Gandon S., and Day T. Evidences of parasite evolution after vaccination. Vaccine 26 (2008) C4-C7
16. Restif O., and Grenfell B.T. Integrating life history and cross-immunity into the evolutionary dynamics of pathogens. Proc. Biol. Sci. 273 (2006) 409-416
17. Gandon S., and Day T. The evolutionary epidemiology of vaccination. J. R. Soc. Interface 4 (2007) 803-817
18. Restif O., and Grenfell B.T. Vaccination and the dynamics of immune evasion. J. R. Soc. Interface 4 (2007) 143-153
19. Ebert D., and Bull J.J. Challenging the trade-off model for the evolution of virulence: is virulence management feasible?. Trends Microbiol. 11 (2003) 15-20
20. Hastings I.M. Complex dynamics and stability of resistance to antimalarial drugs. Parasitology 132 (2006) 615-624
21. Lipsitch M., and Samore M.H. Antimicrobial use and antimicrobial resistance: a population perspective. Emerg. Infect. Dis. 8 (2002) 347-354
22. van Boven M., et al. Pathogen adaptation under imperfect vaccination: implications for pertussis. Proc. Biol. Sci. 272 (2005) 1617-1624
23. Koella J.C., and Turner P. Evolution of parasites. In: Stearns S.C., and Koella J.C. (Eds). Evolution in health and disease (2008), Oxford University Press 229-237
24. Day T., and Gandon S. Applying population-genetic models in theoretical evolutionary epidemiology. Ecol. Lett. 10 (2007) 876-888
25. Martcheva M., et al. Vaccine-induced pathogen strain replacement: what are the mechanisms?. J. R. Soc. Interface 5 (2008) 3-13
26. Gandon S., et al. Imperfect vaccination: some epidemiological and evolutionary consequences. Proc. Biol. Sci. 270 (2003) 1129-1136
27. Holt R.D., et al. Temporal variation can facilitate niche evolution in harsh sink environments. Am. Nat. 164 (2004) 187-200
28. Perron G.G., et al. Source-sink dynamics shape the evolution of antibiotic resistance and its pleiotropic fitness cost. Proc. Biol. Sci. 274 (2007) 2351-2356
29. Russell C.A., et al. The global circulation of seasonal influenza A (H3N2) viruses. Science 320 (2008) 340-346
30. Rambaut A., et al. The genomic and epidemiological dynamics of human influenza A virus. Nature 453 (2008) 615-619
31. Weinstock D.M., and Zuccotti G. The evolution of influenza resistance and treatment. J. Am. Med. Assoc. 301 (2009) 1066-1069
32. Nelson M.I., et al. The origin and global emergence of adamantane resistant A/H3N2 influenza viruses. Virology 388 (2009) 270-278
33. Iannelli M., et al. Strain replacement in an epidemic model with super-infection and perfect vaccination. Math. Biosci. 195 (2005) 23-46
34. Wargo A.R., et al. Competitive release and facilitation of drug-resistant parasites after therapeutic chemotherapy in a rodent malaria model. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 19914-19919
35. Grech K., et al. The impact of immunization on competition within Plasmodium infections. Evolution 62 (2008) 2359-2371
36. de Roode J.C., et al. Competitive release of drug resistance following drug treatment of mixed Plasmodium chabaudi infections. Malar. J. 3 (2004) 33
37. Hall B.G. Predicting the evolution of antibiotic resistance genes. Nat. Rev. Microbiol. 2 (2004) 430-435
38. Zimmerman P.A., et al. Why do we need to know more about mixed Plasmodium species infections in humans?. Trends Parasitol. 20 (2004) 440-447
39. Smith P.A., and Romesberg F.E. Combating bacteria and drug resistance by inhibiting mechanisms of persistence and adaptation. Nat. Chem. Biol. 3 (2007) 549-556
40. Cirz R.T., et al. Inhibition of mutation and combating the evolution of antibiotic resistance. PloS Biol. 3 (2005) 1024-1033
41. Domingo E., et al. Viruses as quasispecies: biological implications. In: Domingo E. (Ed). Quasispecies: Concept and Implications for Virology (2006), Springer 51-82
42. Perales, C. et al. (2009) Counteracting quasispecies adaptability: extinction of a ribavirin-resistant virus mutant by an alternative mutagenic treatment. PLoS ONE 4, e5554 DOI:10.1371/journal.pone.0005554 (www.plosone.org)
43. Domingo E., et al. Viral quasispecies: dynamics, interactions and pathogenesis. In: Domingo E., et al. (Ed). Origin and Evolution of Viruses (2008), Elsevier 87-118
44. Domingo E. Antiviral strategy on the horizon. Virus Res. 107 (2005) 115-116
45. Graci J.D., and Cameron C.E. Therapeutically targeting RNA viruses via lethal mutagenesis. Future Virol. 3 (2008) 553-566
46. Ruiz-Jarabo C.M., et al. Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV). Virology 308 (2003) 37-47
47. Vignuzzi M., et al. Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature 439 (2006) 344-348
48. Cowen L.E. The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype. Nat. Rev. Microbiol. 6 (2008) 187-198
49. Sui J.H., et al. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat. Struct. Mol. Biol. 16 (2009) 265-273
50. Khan, A.M. et al. (2008) Conservation and variability of dengue virus proteins: implications for vaccine design. PloS Negl. Trop. Dis. 2(8):e272 DOI:10.1371/journal.pntd.0000272 (www.plosntds.org)
51. Fenner F. The Florey lecture, biological control, as exemplified by smallpox eradication and myxomatosis. Proc. Biol. Sci. 218 (1983) 259-285
52. Anderson R.M., and May R.M. Coevolution of hosts and parasites. Parasitology 85 (1982) 411-426
53. Fraser C., et al. Variation in HIV-1 set-point viral load: epidemiological analysis and an evolutionary hypothesis. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 17441-17446
54. Gandon S., et al. Imperfect vaccines and the evolution of pathogen virulence. Nature 414 (2001) 751-756
55. Porco T.C., et al. The effect of treatment on pathogen virulence. J. Theor. Biol. 233 (2005) 91-102
56. Ganusov V.V., and Antia R. Imperfect vaccines and the evolution of pathogens causing acute infections in vertebrates. Evolution 60 (2006) 957-969
57. Williams P.D., and Day T. Epidemiological and evolutionary consequences of targeted vaccination. Mol. Ecol. 17 (2008) 485-499
58. Sokurenko E.V., et al. Source-sink dynamics of virulence evolution. Nat. Rev. Microbiol. 4 (2006) 548-555
59. Chattopadhyay S., et al. Haplotype diversity in "source-sink" dynamics of Escherichia coli urovirulence. J. Mol. Evol. 64 (2007) 204-214
60. Bull J.J., and Levin B.R. Evolution of infectious diseases. Science 265 (1994) 1469-1470
61. Parkhill J. Whole-genome analysis of pathogen evolution. In: Stearns S.C., and Koella J.C. (Eds). Evolution in health and disease (2008), Oxford University Press 199-213
62. Repik A., et al. A transgenic mouse model for studying the clearance of blood-borne pathogens via human complement receptor 1 (CR1). Clin. Exp. Immunol. 140 (2005) 230-240
63. Asher D.R., et al. The erythrocyte viral trap: transgenic expression of viral receptor on erythrocytes attenuates coxsackievirus B infection. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 12897-12902
64. de Roode J.C., et al. Virulence and competitive ability in genetically diverse malaria infections. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 7624-7628
65. Bell A.S., et al. Within-host competition in genetically diverse malaria infections: parasite virulence and competitive success. Evolution 60 (2006) 1358-1371
66. de Roode J.C., et al. Host heterogeneity is a determinant of competitive exclusion or coexistence in genetically diverse malaria infections. Proc. Biol. Sci. 271 (2004) 1073-1080
67. Raberg L., et al. The role of immune-mediated apparent competition in genetically diverse malaria infections. Am. Nat. 168 (2006) 41-53
68. Good M.F., et al. Development and regulation of cell-mediated immuneresponses to the blood stages of malaria: implications for vaccine research. Annu. Rev. Immunol. 23 (2005) 69-99
69. Barclay V.C., et al. Mixed allele malaria vaccines: host protection and within-host selection. Vaccine 26 (2008) 6099-6107
70. Mackinnon M.J., and Read A.F. Immunity promotes virulence evolution in a malaria model. PloS Biol. 2 (2004) 1286-1292